PATENT CLAIM ANALYSIS

Application Number: 15960087
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "180000"]

Abstract:
The present invention describes novel and improved dosage forms containing fluticasone propionate for the treatment of conditions associated with inflammation of the esophagus.

Claim (Index 29):
The viscous liquid dosage form of  claim 27 , wherein the sweetener agent is sucralose.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 91.0
- Lexical Diversity: 1.09091
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15612923', '14603224', '15795846', '15293535', '15181462']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7823167473485783
- 35 USC 102 Novelty (BERT): 0.5378121552857271
- Combined Prediction Score: 0.7578662881422932
- Mean Citation Score: 259.03165
- Max Citation Score: 367.7427
- Similarity Product: 217.91603415369988

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test